zur Navigation zum Inhalt

Inhalt

Artikel mit dem Stichwort "chemotherapy":

  • Head and neck cancer: a step forward

    memo - Magazine of European Medical Oncology 2 / 2010

    Head and neck cancers have for a long time been orphan cancers for any trials of individualized treatment, at least in part because the number of active cytotoxic drugs has been for a long time rather restricted.

  • Neue Arzneimittel zur Behandlung der Malaria

    Wiener klinische Wochenschrift 1 / 2010

    Die Entwicklung neuer Medikamente zur Behandlung der Malaria ist ein wichtiges und herausforderndes Forschungsgebiet, da Malaria zu den wichtigsten Infektionserkrankungen gehört und der Erreger, Plasmodium falciparum, eine große Anpassungsfähigkeit besitzt.

  • Pancreatic cancer – ASCO 2009

    memo - Magazine of European Medical Oncology 4 / 2009

    The publication of practice changing clinical data is a rare event in the field of pancreatic cancer. In line with this general statement, oncologists attending or following the ASCO Annual Meeting 2009 were not surprised by being confronted with the study results mainly confirming the already existing evidence.

  • Non-small cell lung cancer – ASCO 2009

    memo - Magazine of European Medical Oncology 4 / 2009

    From May 29 to June 2, the American Society of Clinical Oncology (ASCO) held its annual meeting in Orlando, Florida (USA). The meeting was themed “personalizing cancer care”.

  • St. Gallen 2009 recommendations on the treatment of early breast cancer: consensus and controversy

    memo - Magazine of European Medical Oncology 4 / 2009

    The 11th St. Gallen consensus meeting on the primary treatment of early breast cancer put a special emphasis on a tailored approach for patient subgroups, and by the selection of targetted treatments according to tumour biology.

  • Systemic therapy of soft tissue sarcomas – “nothing new under the sun?” – ASCO 2009

    memo - Magazine of European Medical Oncology 4 / 2009

    The systemic treatment of patients with soft tissue sarcomas is an area of controversies where small progress has been made over the past years. The rarity of the disease in addition to the huge diversity of subtypes is probably to be responsible for the sometimes conflicting data obtained in clinical trials.

  • Treatment of colorectal cancer – ASCO 2009

    memo - Magazine of European Medical Oncology 4 / 2009

    Colorectal cancer is a curable disease in stage II and stage III with higher cure rates if adjuvant chemotherapy is administered and that in most cases is treated with palliative intention in stage IV.

  • SCLC – ASCO 2009

    memo - Magazine of European Medical Oncology 4 / 2009

    For years interest in developing new treatment strategies in SCLC has lagged behind the efforts addressing NSCLC. This trend could easily be followed during the ASCO 2009 meeting.

  • Gastric MALT lymphoma

    memo - Magazine of European Medical Oncology 3 / 2009

    Mucosa-associated lymphoid tissue (MALT) lymphoma is amongst the most common lymphoma entities and comprises about 7% of all newly diagnosed NHL. Roughly 50% of all MALT lymphomas are located in the stomach, where a pathophysiological link with Helicobacter pylori (HP) with consecutive response to HP eradication therapy has been

  • Mature T-cell malignancies: a diagnostic and therapeutic challenge

    memo - Magazine of European Medical Oncology 3 / 2009

    Peripheral T-/NK-cell lymphomas/leukaemias (PTCL/L) comprise a heterogeneous group of haematopoietic tumours, which originate from mature T-/NK-cells, and constitute less than 15% of all non-Hodgkin lymphomas (NHL) in adults of the Western hemisphere.

  • Treatment of diffuse large B-cell lymphomas

    memo - Magazine of European Medical Oncology 3 / 2009

    Over 30 years ago, the combination of cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) was demonstrated to induce complete remissions and long-term disease-free survival in a considerable proportion of lymphoma patients.

  • Role of interdisciplinary strategies in liver metastases

    memo - Magazine of European Medical Oncology 1 / 2009

    Metastases of the liver are a common event in malignancies particularly of the gastrointestinal tract and a leading cause of cancer-related death. Until a few years ago, treatment for these patients was given based on palliative strategies.

      1 / 3  >>

Medizin heute

Aktuelle Printausgaben

Es wird Flash Player 8 benötigt umd das Video anzeigen zu können.